Question 1

Does Ubs own NRXP stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ubs holds 423,115 shares of NRXP (NRX Pharmaceuticals), worth $1.7M.

Question 2

How many shares of NRXP does Ubs own?

Accepted Answer

As of its Q2 2026 13F, Ubs holds 423,115 shares of NRXP (NRX Pharmaceuticals).

Question 3

What is Ubs' NRXP position worth?

Accepted Answer

As of its Q2 2026 13F, Ubs' NRXP position is worth $1.7M.

Question 4

Is Ubs buying or selling NRXP?

Accepted Answer

In Q2 2026, Ubs increased its NRXP position from 25,227 to 423,115 shares.

Question 5

When did Ubs first buy NRXP?

Accepted Answer

Ubs first reported NRXP in its Q2 2024 13F and has listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	423,115	+1577.2%	$1.7M	0.0%	$4.09	41
2026-Q1	Increased	25,227	+613.0%	$53,734	0.0%	$1.80	23
2025-Q4	Decreased	3,538	-97.7%	$9,588	0.0%	$2.63	0
2025-Q3	Increased	152,848	+25.7%	$504,399	0.0%	$3.25	30
2025-Q2	Increased	121,608	+1157x	$396,442	0.0%	$3.42	38
2025-Q1	Decreased	105	-30.0%	$215	0.0%	$2.03	0
2024-Q4	Increased	150	+294.7%	$330	0.0%	$1.53	12
2024-Q3	Decreased	38	-96.5%	$64	0.0%	$1.75	0